Literature DB >> 23942790

Predicted values of exercise capacity in heart failure: where we are, where to go.

Paola Gargiulo1, Sergio Olla, Costanza Boiti, Mauro Contini, Pasquale Perrone-Filardi, Piergiuseppe Agostoni.   

Abstract

Cardiopulmonary exercise testing (CPET) is a procedure widely used in daily clinical activity to investigate cardiac and pulmonary disorders. Peak oxygen consumption (VO2 peak) is the most validated and clinically accepted parameter used to report aerobic capacity in healthy individuals and in different clinical settings. However, peak VO2 is influenced by several factors, whose variability is nowadays particularly evident due to the extensive use of CPET even in very young and very old subgroups of patients. Thus, its diagnostic and prognostic significance may be improved by the use of % of predicted VO2. At present, many sets of normal values are available, making the identification of the most proper max VO2 predicted value a challenging problem. In fact, normal value sets have been obtained from studies whose accuracy was reduced by important limitations, such as small sample size, low grade of heterogeneity of the population enrolled, poor rigorousness of methods, or difficulty in interpreting results. Accordingly, the aim of the present review is threefold: (A) to report some illustrative cases to show how the choice of the normal value set can influence the report of CPET; (B) to describe the most known and used reference value sets, highlighting the main characteristics of sample population, the most important methodological aspects, and the major limitations of the studies; (C) to suggest which equation should be used, if any, and to underline its weakness.

Entities:  

Mesh:

Year:  2014        PMID: 23942790     DOI: 10.1007/s10741-013-9403-x

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  31 in total

1.  Influence of age, sex, body size, smoking, and beta blockade on key gas exchange exercise parameters in an adult population.

Authors:  Sven Gläser; Beate Koch; Till Ittermann; Christoph Schäper; Marcus Dörr; Stephan B Felix; Henry Völzke; Ralf Ewert; James E Hansen
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-08

2.  Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study.

Authors:  B Koch; C Schäper; T Ittermann; T Spielhagen; M Dörr; H Völzke; C F Opitz; R Ewert; S Gläser
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

3.  Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.

Authors:  Mariaconsuelo Valentini; Miriam Revera; Grzegorz Bilo; Gianluca Caldara; Giulio Savia; Katarzyna Styczkiewicz; Sara Parati; Francesca Gregorini; Andrea Faini; Giovanna Branzi; Gabriella Malfatto; Damiano Magrì; Piergiuseppe Agostoni; Gianfranco Parati
Journal:  Cardiovasc Ther       Date:  2011-03-11       Impact factor: 3.023

4.  Impaired heart rate responses and exercise capacity in heart failure patients with paced baseline rhythms.

Authors:  Amaar Ujeyl; Lynne W Stevenson; Erin K West; Mahoto Kato; Mark Liszkowski; Patricia Campbell; Daniel E Forman
Journal:  J Card Fail       Date:  2010-12-13       Impact factor: 5.712

Review 5.  Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure.

Authors:  K T Weber; J S Janicki; P A McElroy
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

6.  Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.

Authors:  Lars H Lund; Keith D Aaronson; Donna M Mancini
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

7.  Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study.

Authors:  Daniel E Forman; Robert Clare; Dalane W Kitzman; Stephen J Ellis; Jerome L Fleg; Toni Chiara; Gerald Fletcher; William E Kraus
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

8.  Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age.

Authors:  S P Blackie; M S Fairbarn; G N McElvaney; N J Morrison; P G Wilcox; R L Pardy
Journal:  Am Rev Respir Dis       Date:  1989-06

9.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

10.  Normal standards for an incremental progressive cycle ergometer test.

Authors:  N L Jones; L Makrides; C Hitchcock; T Chypchar; N McCartney
Journal:  Am Rev Respir Dis       Date:  1985-05
View more
  6 in total

1.  Benefits of a Supervised Ambulatory Outpatient Program in a Cardiovascular Rehabilitation Unit Prior to a Heart Transplant: A Case Study.

Authors:  Antoine Poty; Florent Krim; Philippe Lopes; Yves Garaud; Pierre-Marie Leprêtre
Journal:  Front Cardiovasc Med       Date:  2022-05-19

2.  Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.

Authors:  Wilson Nadruz; Erin West; Mário Santos; Hicham Skali; John D Groarke; Daniel E Forman; Amil M Shah
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

3.  Comparison of V̇O2-Kinetic Parameters for the Management of Heart Failure.

Authors:  Jonathan Wagner; Max Niemeyer; Denis Infanger; Otmar Pfister; Jonathan Myers; Arno Schmidt-Trucksäss; Raphael Knaier
Journal:  Front Physiol       Date:  2021-11-25       Impact factor: 4.566

4.  Comparison of the FRIEND and Wasserman-Hansen Equations in Predicting Outcomes in Heart Failure.

Authors:  Jonathan Myers; Christina G de Souza E Silva; Ross Arena; Leonard Kaminsky; Jeffrey W Christle; Vincent Busque; Euan Ashley; Kegan Moneghetti
Journal:  J Am Heart Assoc       Date:  2021-10-23       Impact factor: 5.501

5.  Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients.

Authors:  Tianzhao Xu; Qiulian Zhou; Lin Che; Saumya Das; Lemin Wang; Jinfa Jiang; Guanghe Li; Jiahong Xu; Jianhua Yao; Hongbao Wang; Yue Dai; Junjie Xiao
Journal:  Oncotarget       Date:  2016-03-15

6.  Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction.

Authors:  Elisabetta Salvioni; Ugo Corrà; Massimo Piepoli; Sara Rovai; Michele Correale; Stefania Paolillo; Mario Pasquali; Damiano Magrì; Giuseppe Vitale; Laura Fusini; Massimo Mapelli; Carlo Vignati; Rocco Lagioia; Rosa Raimondo; Gianfranco Sinagra; Federico Boggio; Lorenzo Cangiano; Giovanna Gallo; Alessandra Magini; Mauro Contini; Pietro Palermo; Anna Apostolo; Beatrice Pezzuto; Alice Bonomi; Angela B Scardovi; Pasquale Perrone Filardi; Giuseppe Limongelli; Marco Metra; Domenico Scrutinio; Michele Emdin; Lucrezia Piccioli; Carlo Lombardi; Gaia Cattadori; Gianfranco Parati; Sergio Caravita; Federica Re; Mariantonietta Cicoira; Maria Frigerio; Francesco Clemenza; Maurizio Bussotti; Elisa Battaia; Marco Guazzi; Francesco Bandera; Roberto Badagliacca; Andrea Di Lenarda; Giuseppe Pacileo; Claudio Passino; Susanna Sciomer; Giuseppe Ambrosio; Piergiuseppe Agostoni
Journal:  ESC Heart Fail       Date:  2020-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.